We’ve recently updated our valuation analysis.

MicroBase Technology Valuation

Is 3184 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 3184?

Other financial metrics that can be useful for relative valuation.

3184 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue4.2x
Enterprise Value/EBITDA-34.4x
PEG Ration/a

Price to Sales Ratio vs Peers

How does 3184's PS Ratio compare to its peers?

The above table shows the PS ratio for 3184 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPSEstimated GrowthMarket Cap
Peer Average4.7x
6815 Diamond Biotechnology
2.1xn/aNT$928.0m
4188 AmCad BioMed
10.5xn/aNT$785.0m
4744 CVC Technologies
1.1xn/aNT$1.1b
7595 Pharmigene
5.2xn/aNT$647.6m
3184 MicroBase Technology
4.6xn/aNT$838.9m

Price-To-Sales vs Peers: 3184 is good value based on its Price-To-Sales Ratio (4.6x) compared to the peer average (4.7x).


Price to Earnings Ratio vs Industry

How does 3184's PE Ratio compare vs other companies in the TW Medical Equipment Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a-6.4%
n/an/an/a

Price-To-Sales vs Industry: 3184 is expensive based on its Price-To-Sales Ratio (4.6x) compared to the TW Medical Equipment industry average (2.3x)


Price to Sales Ratio vs Fair Ratio

What is 3184's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

3184 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio4.6x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate 3184's Price-To-Sales Fair Ratio for valuation analysis.


Share Price vs Fair Value

What is the Fair Price of 3184 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 3184 (NT$10.45) is trading above our estimate of fair value (NT$2.88)

Significantly Below Fair Value: 3184 is trading above our estimate of fair value.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies